Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of the Presence and Cardiac Functional Effects of Anti-NaV1.5 Autoantibodies in Patients With Metastatic Tumors

NCT07364656 is registered in ClinicalTrials.gov with IRCCS Policlinico S. Donato as lead sponsor.

NCT NCT07364656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07364656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of the Presence and Cardiac Functional Effects of Anti-NaV1.5 Autoantibodies in Patients With Metastatic Tumors
Lead sponsor
IRCCS Policlinico S. Donato
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
December 31, 2026
Enrollment
196 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoantibodies screening, breast cancer females, brugada syndrome (brs), colon cancer, ecg abnormalities